Vitamin C: possible cancer-killing promise

September 12, 2005

High-dose intravenous vitamin C may be effective in treating cancer, newly published research indicates.

Studies during the 1970s first suggested administration of high doses of ascorbate might provide a clinical benefit for treating cancer, but later studies using the same high doses found no benefit.

However, researchers now say the original studies used intravenous and oral ascorbate, while subsequent studies used only oral administration. Recognizing those differences might account for the disparate clinical outcomes, Mark Levine and colleagues at the National Institutes of Health reexamined intravenous ascorbate therapy in cultured cancer cell lines.

The researchers found ascorbate killed cancer cells at concentrations that would only be achievable through intravenous infusion. Normal cells were not affected by ascorbate at any concentration.

Additionally, the scientists report ascorbate treatment led to the formation of hydrogen peroxide, a chemical that can kill cells, suggesting a potential mechanism for the therapy.

The research appears in this week's online, early edition of the Proceedings of the National Academy of Sciences.

Copyright 2005 by United Press International

Explore further: Vitamin C in the body can be tracked by fluorescence

Related Stories

Vitamin C in the body can be tracked by fluorescence

January 25, 2018

Vitamin C is best known as a nutrient. In high enough doses, however, vitamin C also shows potential against many cancers, according to recent studies. To successfully develop vitamin C (chemically named ascorbic acid) as ...

Why high-dose vitamin C kills cancer cells

January 9, 2017

Vitamin C has a patchy history as a cancer therapy, but researchers at the University of Iowa believe that is because it has often been used in a way that guarantees failure.

Vitamin C injections slow tumor growth in mice

August 4, 2008

High-dose injections of vitamin C, also known as ascorbate or ascorbic acid, reduced tumor weight and growth rate by about 50 percent in mouse models of brain, ovarian, and pancreatic cancers, researchers from the National ...

Support for adjunctive vitamin C treatment in cancer

March 6, 2009

Serious flaws in a recent study, which concluded that high doses of vitamin C reduce the effectiveness of chemotherapeutic drugs in the treatment of cancer, are revealed in the current issue of Alternative and Complementary ...

Recommended for you

Rubbery carbon aerogels greatly expand applications

March 19, 2018

Researchers have designed carbon aerogels that can be reversibly stretched to more than three times their original length, displaying elasticity similar to that of a rubber band. By adding reversible stretchability to aerogels' ...

Termite queen, king recognition pheromone identified

March 19, 2018

Researchers at North Carolina State University have for the first time identified a specific chemical used by the higher termite castes—the queens and the kings—to communicate their royal status with worker termites. ...

Scientists have a new way to gauge the growth of nanowires

March 19, 2018

In a new study, researchers from the U.S. Department of Energy's (DOE) Argonne and Brookhaven National Laboratories observed the formation of two kinds of defects in individual nanowires, which are smaller in diameter than ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.